Sagemcom and Com Hem First to Launch Wi-Fi 6 Cable Gateway on Multi-Gigabit Broadband Market
20.11.2019 19:22:00 EET | Business Wire | Press release
THIS NEXT GENERATION HOME GATEWAY ACHIEVES BREATHTAKING PERFORMANCE AND ALLOWS COM HEM CUSTOMERS REACHING MULTI-GIGABIT SPEEDS AND EXPERIENCING ENHANCED CONNECTIVITY.
Designed by Sagemcom, DOCSIS 3.1 eMTA F@st 3896 maximises the distribution over Wi-Fi and 2.5Gbps LAN of the bandwidth coming from the DOCSIS 3.1 network.
This product implements a true Wi-Fi 6 solution, offering better spectrum efficiency, higher network capacity, enhanced user experience and reduced latency on the home networking. It features the latest wireless technologies including OFDMA and 1024QAM modulation and it enables multi-device usages through an efficient bandwidth sharing. It is designed to maximize the throughput for each connected device in the home, to extend the Wi-Fi range and to reduce the power consumption of the connected devices.
In addition, DOCSIS 3.1 eMTA F@st 3896 offers advanced broadband services with Sagemcom Swan®.It is also available with RDK-B and its open partner ecosystem.
DOCSIS 3.1 eMTA F@st 3896 better supports the connected homes with multiple active devices. It accelerates everything that consumers do online today including video streaming, smart home automation, gaming and downloads. It is also ready to support future services and experiences such as 8K video, IA applications, home network security, advanced QoS and more.
"The majority of our customers use wireless connection at home and therefore it is important to us that we have the absolute fastest broadband speeds. Now we are the first Swedish operator to launch WiFi 6, and thanks to that we can offer the fastest speed over WiFi ever achieved among the biggest operators in Sweden. Once again, Com Hem proves that we offer the best surfing experience that you can get in your home", says Joakim Öhrström, Head of Broadband and TV at Com Hem.
About Sagemcom
A French high-tech group of international dimensions, Sagemcom operates on the broadband (set-top boxes, Multi-Gigabit gateways), smart city and Internet of Things (founding member of LoRa Alliance) markets.
With a revenue of 2.1 billion euros, Sagemcom employs 5,500 people on five continents. Sagemcom aims to stay a world leader in communicating terminals with high added value.
www.sagemcom.com
//
www.facebook.com/SagemcomOfficial
//
https://twitter.com/Sagemcom
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191120005687/en/
Contact information
Media
Sylvaine COULEUR
presse@sagemcom.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 13:00:00 EET | Press release
Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe
SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 12:40:00 EET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amortization expense and impairment loss on intangible assets to income from operations was
NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 12:00:00 EET | Press release
NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding to 30 by the end of 2026 Introduction of NIQ’s exclusive EQ2 metric, multiplying units by number in pack to reflect true consumption “The pace of
European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 09:47:00 EET | Press release
European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 02:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom